Bayesian Capital Management’s Cineverse CNVS Stock Holding History

Bayesian Capital Management’s Portfolio CNVS Stock Details CNVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,160	Closed	-$27K	–	793
2021 Q4	$27K	Buy	+1,160	New	+$44.2K	0.01%	358

Other funds holding CNVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KPW

Kore Private Wealth New York $554M AUM 17.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bayesian Capital Management's CNVS Position: Q1 2022 in Review

Bayesian Capital Management sold out of Cineverse (CNVS) in Q1 2022, closing a stake of 1,160 shares — an estimated $27K sold.

Bayesian Capital Management first reported a position in CNVS in Q4 2021 and held it in 1 quarter. The position peaked at $27K in Q4 2021. 49 funds tracked by Wall St. Rank hold CNVS as of Q1 2022.

Bayesian Capital Management reported no remaining Cineverse position as of Q1 2022 after selling out during the quarter.
Bayesian Capital Management sold 1,160 Cineverse shares in Q1 2022, an estimated $27K.
Bayesian Capital Management first reported a position in Cineverse in Q4 2021 and held it in 1 quarter.
Bayesian Capital Management's Cineverse position peaked at $27K in Q4 2021.
49 funds tracked by Wall St. Rank held Cineverse as of Q1 2022.

Based on Bayesian Capital Management's 13F filing for Q1 2022, filed 16 May 2022.